Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	28^th August 2023

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,122,940 (1.801%)		15,842 (0.007%)
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	1,737,700 (0.759%)		1,946,500 (0.850%)
Total	5,860,640 (2.560%)		1,962,342 (0.857%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Sale	2,139	112.61
Sale	415	112.62
Sale	1,740	112.63
Sale	100	112.64
Sale	900	112.65
Sale	7,190	112.68
Sale	10	112.58
Sale	2,300	112.60
Sale	100	112.66
Sale	106	112.67
Purchase	200	112.55
Sale	100	112.55
Purchase	270	112.61
Purchase	2,474	112.51
Purchase	497	112.62
Purchase	2,342	112.48
Purchase	312	112.57
Purchase	3,473	112.49
Purchase	5,533	112.50
Sale	100	112.80
Sale	150	112.79
Purchase	1,200	112.53
Purchase	1,208	112.46
Purchase	900	112.34
Purchase	800	112.25
Purchase	2,351	112.47
Purchase	830	112.54
Purchase	712	112.52
Purchase	200	112.37
Purchase	5,387	112.15
Purchase	200	112.10
Purchase	24	112.56
Purchase	300	112.58
Purchase	571	112.60
Purchase	400	112.59
Purchase	500	112.45
Purchase	141	112.43
Purchase	800	112.38
Purchase	300	112.35
Purchase	700	112.32
Purchase	2,400	112.31
Purchase	1,161	112.27
Purchase	1,100	112.28
Purchase	544	112.26
Purchase	21,980	112.17
Purchase	1,193	112.14
Purchase	6,065	112.16
Purchase	400	112.42
Purchase	1,036	112.11
Purchase	214	112.40
Purchase	627	112.36
Purchase	792	112.33
Purchase	300	112.20
Purchase	915	112.30
Purchase	100	112.21
Purchase	1,100	112.18
Purchase	300	112.22
Purchase	100	112.24
Purchase	572	112.44
Purchase	306	112.41
Purchase	233	112.39
Purchase	800	112.29
Purchase	100	112.12
Purchase	34	112.13
Purchase	100	112.19
Purchase	100	112.55
Purchase	1	112.61
Purchase	12	112.49
Purchase	22	112.47
Purchase	35	112.37
Purchase	6,649	112.15
Sale	6,775	112.58
Purchase	55	112.31
Purchase	30	112.27
Purchase	1	112.17
Purchase	11	112.16
Purchase	24	112.30
Purchase	12	112.41
Purchase	10	112.13
Sale	306	112.72
Sale	359	112.71
Sale	177	112.69
Purchase	258	112.55
Purchase	7,746	112.61
Sale	3,933	112.61
Purchase	494	112.51
Purchase	2,556	112.62
Sale	1,564	112.62
Purchase	857	112.48
Purchase	3,101	112.57
Purchase	382	112.49
Sale	12	112.49
Purchase	6,870	112.50
Purchase	200	112.80
Sale	2,218	112.80
Purchase	600	112.77
Sale	6,956	112.77
Purchase	343	112.79
Sale	2,938	112.79
Purchase	101	112.53
Purchase	818	112.34
Purchase	2,288	112.74
Sale	5,277	112.74
Purchase	2,469	112.63
Purchase	7,712	112.75
Sale	7,192	112.75
Purchase	2,881	112.73
Sale	3,249	112.73
Purchase	2,668	112.72
Sale	1,564	112.72
Purchase	472	112.71
Sale	2,238	112.71
Purchase	935	112.64
Sale	2,581	112.64
Purchase	10,937	112.25
Purchase	200	112.81
Sale	2,652	112.81
Purchase	2,847	112.69
Sale	10,434	112.78
Purchase	13	112.88
Purchase	273	112.47
Purchase	494	112.54
Purchase	43	112.52
Purchase	383	112.37
Sale	100	112.85
Purchase	2,300	112.15
Purchase	2,139	112.70
Sale	6,760	112.70
Purchase	2,438	112.65
Sale	320	112.65
Purchase	5,233	112.10
Sale	100	112.86
Sale	200	112.83
Purchase	2,944	112.68
Sale	7,024	112.76
Purchase	45	113.06
Purchase	100	113.13
Purchase	1,292	112.56
Purchase	11,701	112.58
Purchase	286	112.05
Purchase	2,959	112.60
Sale	3,239	112.60
Purchase	3,671	112.59
Sale	767	112.59
Purchase	200	112.82
Purchase	2,202	112.66
Purchase	452	112.45
Purchase	234	112.43
Purchase	500	112.31
Purchase	300	112.27
Purchase	211	112.28
Purchase	103	112.17
Purchase	1,100	112.16
Purchase	745	112.42
Purchase	246	112.11
Purchase	240	112.40
Purchase	1,153	112.36
Purchase	756	112.33
Purchase	500	112.67
Sale	2,635	112.67
Purchase	566	112.18
Purchase	535	112.22
Purchase	500	112.24
Purchase	345	112.44
Purchase	211	112.29

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price (USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	29^th August 2023
Contact name	Stephen Glasper
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	100,300	90.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Written	284,900	60.00	American	12/15/2023
IE00BQPVQZ61	Put Option	Written	100,000	65.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Purchased	55,000	70.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Written	41,500	45.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	250,000	85.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	152,500	110.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	4,500	110.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	100,000	100.00	American	12/15/2023
IE00BQPVQZ61	Call Option	Written	100,000	110.00	American	12/15/2023
IE00BQPVQZ61	Call Option	Written	3,400	100.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	2,800	100.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Written	50,000	85.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Purchased	150,000	85.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	2,600	90.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	40,900	100.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Purchased	41,500	65.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Written	600	100.00	American	10/20/2023
IE00BQPVQZ61	Put Option	Purchased	100,000	70.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	300	100.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Purchased	300	100.00	American	15/09/2023
IE00BQPVQZ61	Put Option	Written	100,000	60.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	35,000	110.00	American	15/09/2023
IE00BQPVQZ61	Call Option	Purchased	535,200	110.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Written	554,800	115.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	220,000	90.00	American	15/09/2023
IE00BQPVQZ61	Call Option	Purchased	18,000	105.00	American	15/09/2023
IE00BQPVQZ61	Call Option	Written	400	105.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Written	400	105.00	American	17/11/2023
IE00BQPVQZ61	Put Option	Written	312,000	70.00	American	10/20/2023
IE00BQPVQZ61	Put Option	Purchased	327,000	95.00	American	10/20/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1157500

Time of Receipt (offset from UTC): 20230829T133146+0100